Santalis Article on Phase 2 Trials http://www.businesswire.com/news/ho...-Pharmaceuticals-Initiates-Phase-2-Study-Mild
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025